Today: 20 May 2026
Browse Category

NASDAQ:SLDP 6 October 2025 - 5 November 2025

Solid Power (SLDP) Charges Ahead: Will Solid-State Batteries Supercharge Its Stock?

Solid Power (SLDP) Charges Ahead: Will Solid-State Batteries Supercharge Its Stock?

Solid Power, Inc., based in Colorado, develops all-solid-state batteries for electric vehicles using a proprietary sulfide-based solid electrolyte. The company, which went public via SPAC in late 2021 and trades as SLDP, licenses its technology and sells materials rather than manufacturing batteries. Ford, BMW, and SK Innovation are key partners. SLDP stock has risen over 400% in the past year, reaching a $1.3 billion market cap.
QuantumScape (QS) Stock Rockets on Solid-State Battery Breakthrough – Analysts Split on Future

QuantumScape (QS) Stock Rockets 180% Amid Solid-State Battery Breakthroughs – What Analysts Are Saying

QuantumScape reported a Q3 2025 net loss of $105.8 million, or –$0.18 per share, slightly beating estimates. Shares surged to the mid-$17 range by October 31, up about 170–180% year-to-date, despite no revenue. The company began shipping B1 prototype solid-state cells and ended Q3 with $1 billion in cash. Volkswagen’s PowerCo and Corning signed new deals; analysts remain split on valuation.
QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape’s High-Voltage Surge: Solid-State Battery Breakthrough Sends QS Stock Soaring (Oct 2025 Update)

QuantumScape shares closed at $15.92 on Oct. 3, up 11% for the day and 170% year-to-date, after announcing a partnership with Corning to co-develop battery separators. At the Munich auto show, Volkswagen’s Ducati prototype using QuantumScape cells demonstrated rapid charging and high energy density. Most analysts still rate the stock “Sell” or “Hold,” citing a lack of product revenue.
QuantumScape Stock Soars on Solid-State Battery Breakthrough – 3-Day Rally and Sector Shake-Up

QuantumScape Stock Soars on Solid-State Battery Breakthrough – 3-Day Rally and Sector Shake-Up

QuantumScape shares closed at $15.92 on Oct 3, up 11.3% and near a 52-week high after announcing a co-development deal with Corning for ceramic battery separators. The stock has surged about 170% year-to-date. Trading volume spiked as the rally triggered momentum buying. Most analysts still rate QS a “Sell/Reduce,” citing no revenue and a $9 billion valuation.

Stock Market Today

  • Stock Market Continues Modest Pullback as Leading Growth Stocks Hold
    May 19, 2026, 7:45 PM EDT. The stock market extended its losing streak to three sessions on Tuesday, marking a modest and orderly pullback. Despite the slump, leading growth stocks demonstrated resilience, showing signs of underlying strength amid broader market pressure. Investors are watching carefully as the overall market digests recent gains, while specific oil and gas companies attract attention for potential opportunities. This cautious environment suggests investors are balancing profit-taking with selective buying in sectors showing robust performance.

Latest articles

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

20 May 2026
GCL Global Holdings shares jumped to $1.00 after hours Tuesday, up 132%, following news that ADATA Technology invested another $10 million in its 4Divinity unit. The stock had closed regular trading at $0.43, below Nasdaq’s $1 minimum. Recent filings still warn of listing and execution risks. GCL reported first-half revenue up 94% to $98.7 million but posted a net loss of $5.6 million.
James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Go toTop